Dan Chan
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 9
- HER2/EGFR in Cancer Research 4
- Colorectal Cancer Treatments and Studies 2
- Lung Cancer Research Studies 2
-
- Lung Cancer Treatments and Mutations 8
- Brain Metastases and Treatment 1
- Co-authors
- Paul A. Bunn (5 shared papers)Barbara A. Helfrich (2 shared papers)David Raben (2 shared papers)Di Zheng (2 shared papers)Barbara Frederick (1 shared paper)Christopher D. Coldren (1 shared paper)Gary L. Johnson (1 shared paper)Yayi He (4 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Journal of Thoracic Oncology (2 papers)Molecular Cancer Therapeutics (1 paper)Seminars in Oncology (1 paper)Oncotarget (1 paper)
- Partner nations
- United StatesChinaSingapore
In The Last Decade
Dan Chan
13 papers receiving 512 citations
Peers
Comparison fields: 5 of 68
- Oncology 287
- Reproductive Medicine 55
- Pulmonary and Respiratory Medicine 194
- Cancer Research 84
- Molecular Biology 250
Countries citing papers authored by Dan Chan
This map shows the geographic impact of Dan Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Chan more than expected).
Fields of papers citing papers by Dan Chan
This network shows the impact of papers produced by Dan Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Chan. The network helps show where Dan Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 224 | |
| 2 | 2002 | 116 | |
| 3 | 2007 | 85 | |
| 4 | 2009 | 42 | |
| 5 | 2016 | 27 | |
| 6 | 2016 | 20 | |
| 7 | 2006 | 4 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 3 | |
| 10 | 2012 | 2 | |
| 11 | 2005 | 2 | |
| 12 | Using solenoid valves for proportional pilot pressure control in miniexcavators | 1995 | 2 |
| 13 | 2016 | 1 |
About Dan Chan
Dan Chan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Organic Chemistry and Surgery, having authored 13 papers that have together received 532 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), HER2/EGFR in Cancer Research (4 papers), Colorectal Cancer Treatments and Studies (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Lung Cancer Research Studies (2 papers), Brain Metastases and Treatment (1 paper), Cancer Genomics and Diagnostics (1 paper) and Mechanical Engineering Research and Applications (1 paper). The work is most often cited by research in Oncology (287 citations), Reproductive Medicine (55 citations), Pulmonary and Respiratory Medicine (194 citations), Cancer Research (84 citations) and Molecular Biology (250 citations). Dan Chan has collaborated with scholars based in United States, China and Singapore. Frequent co-authors include Paul A. Bunn, Barbara A. Helfrich, David Raben, Di Zheng, Barbara Frederick, Christopher D. Coldren, Gary L. Johnson, Yayi He, Caicun Zhou and Karen H. Lu. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Molecular Cancer Therapeutics, Seminars in Oncology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.